NasdaqCM - Nasdaq Real Time Price USD
Tonix Pharmaceuticals Holding Corp. (TNXP)
18.83
-0.11
(-0.58%)
At close: May 9 at 4:00:01 PM EDT
18.83
0.00
(0.00%)
After hours: May 9 at 7:58:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| Low Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| High Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| Year Ago EPS | -576 | -464.22 | -108.41 | -11.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 2.55M | 2.65M | 11.1M | 98.7M |
| Low Estimate | 2.5M | 2.5M | 11.1M | 31.3M |
| High Estimate | 2.6M | 2.8M | 11.1M | 166.1M |
| Year Ago Sales | 2.48M | 2.21M | 10.09M | 11.1M |
| Sales Growth (year/est) | 2.74% | 20.02% | 9.97% | 789.19% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1,136 | -720 | -736 | -- |
| EPS Actual | -576 | -464.22 | -25.56 | -10.18 |
| Difference | 560 | 255.78 | 710.44 | -- |
| Surprise % | 49.30% | 35.53% | 96.53% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| 7 Days Ago | -640 | -672 | -2,784 | 0 |
| 30 Days Ago | -640 | -672 | -2,784 | 0 |
| 60 Days Ago | -640 | -672 | -2,784 | 0 |
| 90 Days Ago | -640 | -672 | -2,784 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TNXP | 99.46% | 99.42% | 89.03% | 60.72% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Noble Capital Markets: Outperform to Outperform | 3/20/2025 |
| Maintains | Alliance Global Partners: Buy to Buy | 7/22/2024 |
| Initiated | Dawson James: Buy | 2/28/2024 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/1/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 6/2/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/31/2021 |
Related Tickers
NCNA NuCana plc
0.0420
-59.18%
KTTA Pasithea Therapeutics Corp.
0.8310
-13.44%
PLRZ Polyrizon Ltd.
0.3747
-36.58%
PTCT PTC Therapeutics, Inc.
44.23
+4.05%
JAGX Jaguar Health, Inc.
8.51
-2.13%
SMMT Summit Therapeutics Inc.
23.96
-2.80%
IOVA Iovance Biotherapeutics, Inc.
1.7500
-44.79%
OCGN Ocugen, Inc.
0.6700
-2.81%
IBRX ImmunityBio, Inc.
2.0700
-0.96%
TGTX TG Therapeutics, Inc.
33.64
-0.65%